Find clinical trials for your condition. Select a disease below to see recruiting studies, treatment pathways, and how to participate.
NSCLC — adenocarcinoma, squamous cell, large cell
TNBC, HER2+, HR+, metastatic
Localised, HSPC, CRPC, post-chemo
Colon, rectal, bowel cancer
NHL, Hodgkin, AML, ALL, CLL, Myeloma, MDS
Advanced, metastatic, adjuvant
Epithelial, recurrent, BRCA+
Adenocarcinoma, neoadjuvant, metastatic
Clear cell, VEGF, immunotherapy
GBM, temozolomide, novel therapies
AML, ALL, CML, CLL subtypes
Hodgkin, DLBCL, follicular, CAR-T
Papillary, medullary, anaplastic, RAI-refractory
NMIBC, muscle-invasive, metastatic urothelial
HCC, cholangiocarcinoma, FGFR2+, IDH1
Immunotherapy, stem cell therapy, and closed-loop insulin delivery trials
Catheter ablation, anticoagulation, and device therapy trials
Vascular dementia, Lewy body, and frontotemporal dementia trials
Novel pain modulators, neuromodulation, and digital therapy trials
Microbiome therapies, novel topicals, and laser treatment trials
Immune modulation, metabolic, neurorehabilitation
Neuromodulation, drug therapies, and sound-based treatments
Novel urate-lowering drugs, anti-inflammatory agents, and lifestyle trials
Gluten desensitisation, vaccine therapy, and enzyme supplement trials
RRMS, SPMS, PPMS — DMT pathways
Levodopa, DBS, disease-modifying therapies
MCI, early onset, APOE4+, anti-amyloid
Focal, generalised, drug-resistant
Ischaemic, haemorrhagic, recovery
Chronic, episodic, cluster headache
Acute, treatment-resistant, negative symptoms
ALS, gene therapy, neuroprotective, SOD1, C9orf72
GDMT, devices, advanced therapies
Bronchodilators, triple therapy, biologics
GLP-1, SGLT2, insulin pathways
Severe, eosinophilic, allergic — biologics
Essential, resistant, pulmonary
GLP-1 agonists, bariatric surgery candidates
CKD stages 3-5, dialysis, transplant
DMARDs, biologics, JAK inhibitors
IBD, immunosuppressants, biologics
IBD, 5-ASAs, biologics, JAK inhibitors
SLE, lupus nephritis, cutaneous lupus
Plaque, nail, psoriatic arthritis, biologics
Moderate-severe, Dupilumab, JAK inhibitors
IBS-C, IBS-D, IBS-M — new therapies
Deep endometriosis, hormonal, non-hormonal, fertility
GLP-1 therapies, anti-androgens, fertility
Next-gen HRT, non-hormonal, cognitive
Wet AMD, dry AMD, geographic atrophy
Open-angle, angle-closure, neuroprotection
Post-menopausal, male, glucocorticoid-induced
Neuropathic, central sensitisation, non-opioid
Neuromodulation, targeted drug delivery, cannabinoids
Regenerative medicine, neuromodulation, digital therapy
OSA, CPAP alternatives, hypoglossal stimulation
CFTR modulators, gene therapy, lung function
Don't see your condition? Search all trials from the main page.